Hoping to advance cheaper pneumonia vaccine, PnuVax picks up $29.4M Gates grant
admin 3rd October 2017 Uncategorised 0The world already has a super-successful pneumococcal conjugate vaccine in Pfizer’s Prevnar 13, but that isn’t stopping PnuVax from pushing ahead with its own program. As it works toward its goal of eventually licensing a vaccine and providing low-cost doses to developing countries, the company will have a sum of money to lean on.
More: Hoping to advance cheaper pneumonia vaccine, PnuVax picks up .4M Gates grant
Source: fierce